Cargando…

Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials

OBJECTIVE: We studied the safety and efficacy of hydroxychloroquine (HCQ) as pre-exposure prophylaxis for COVID-19 in healthcare workers (HCWs), using a meta-analysis of randomised controlled trials (RCTs). DATA SOURCES: PubMed and EMBASE databases were searched to identify randomised trials studyin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Hwanhee, Friedland, Anne, Hu, Mengyi, Anstrom, Kevin J, Halabi, Susan, McKinnon, John E, Amaravadi, Ravi, Rojas-Serrano, Jorge, Abella, Benjamin S, Portillo-Vázquez, Angélica Margarita, Woods, Christopher W, Hernandez, Adrian F, Boulware, David R, Naggie, Susanna, Rajasingham, Radha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276967/ https://www.ncbi.nlm.nih.gov/pubmed/37328184 http://dx.doi.org/10.1136/bmjopen-2022-065305

Ejemplares similares

Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)
por: Naggie, Susanna, et al.
Publicado: (2023)

Routine Cryptococcal Antigen Screening in Solid Organ Transplant Recipients: Is it Time to Save Lives and Money?
por: George, Ige, et al.
Publicado: (2017)

Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
por: Rojas-Serrano, Jorge, et al.
Publicado: (2022)

Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial
por: Labbe, Vincent, et al.
Publicado: (2022)

Prophylactic Antibiotics in Hip Fracture Surgery: A Randomized Prospective Study
por: Ahmed, Syed Kamran, et al.
Publicado: (2023)

Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials
por: Izcovich, Ariel, et al.
Publicado: (2022)

Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
por: Pastick, Katelyn A, et al.
Publicado: (2020)

Does antiretroviral therapy initiation increase sexual risk taking in Kenyan female sex workers? A retrospective case–control study
por: Mawji, Elysha, et al.
Publicado: (2012)

Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial
por: Ried, Karin, et al.
Publicado: (2021)

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda
por: Lofgren, Sarah M., et al.
Publicado: (2018)

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study
por: Ponatshego, Ponego Lloyd, et al.
Publicado: (2019)

Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study
por: McKinnon, John E., et al.
Publicado: (2022)

Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Rajasingham, Radha, et al.
Publicado: (2012)

Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
por: Rajasingham, Radha, et al.
Publicado: (2014)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: protocol for a cohort study in Montreal, Canada
por: Zinszer, Kate, et al.
Publicado: (2021)

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
por: Larivière, Ynke, et al.
Publicado: (2021)

Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19
por: Shabani, Minoosh, et al.
Publicado: (2021)

Prophylactic use of hydroxychloroquine among healthcare workers in a case-control study
por: Kunte, Renuka, et al.
Publicado: (2020)

Use of Ceftazidime-Avibactam in the Treatment of Clinical Syndromes With Limited Treatment Options: A Retrospective Study
por: Radha, Sneha, et al.
Publicado: (2023)

Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100
por: Kwizera, Richard, et al.
Publicado: (2014)

The relationship between mental health and risk of active tuberculosis: a systematic review
por: Hayward, Sally E, et al.
Publicado: (2022)

Hydroxychloroquine for COVID19: The curtains close on a comedy of errors
por: Schwartz, Ilan S, et al.
Publicado: (2022)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
por: Arshad, Samia, et al.
Publicado: (2020)

Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
por: Lofgren, Sarah M, et al.
Publicado: (2020)

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Cytokines in Infectious Diseases
por: Friedland, Jon S
Publicado: (1998)

A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19
por: Zervos, Marcus, et al.
Publicado: (2020)

LB1528C. Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
por: Naggie, Susanna
Publicado: (2022)

Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5–adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023)

The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers
por: MacDougall, D M, et al.
Publicado: (2015)

A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19—A Call for Clinical Trials
por: Pastick, Katelyn A, et al.
Publicado: (2020)

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19
por: Fram, Georgi, et al.
Publicado: (2021)

Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial
por: Said, Bibie, et al.
Publicado: (2022)

Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis
por: Rajasingham, Radha, et al.
Publicado: (2019)

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro
por: Clementi, Nicola, et al.
Publicado: (2020)

Impact of Prophylactic Hydroxychloroquine on People at High Risk of COVID-19: A Systematic Review and Meta-Analysis
por: Hernandez, Adrian V., et al.
Publicado: (2021)

Prophylactic Use of Hydroxychloroquine (HCQS) in COVID-19: A Questionnaire-Based Study in Health Care Professionals
por: Rangari, Gaurav Manikrao, et al.
Publicado: (2022)

Zoonotic Sporotrichosis Related to Cat Contact: First Case Report from Panama in Central America
por: Rios, Margarita E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k3j57mijnompe3necot69b882r